应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06998 嘉和生物
未开盘 01-12 16:08:28
2.400
-0.190
-7.34%
最高
2.700
最低
2.390
成交量
312.90万
今开
2.700
昨收
2.590
日振幅
11.97%
总市值
48.26亿
流通市值
48.26亿
总股本
20.11亿
成交额
769.25万
换手率
0.16%
流通股本
20.11亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
嘉和生物盘中异动 早盘股价大跌5.02%
市场透视 · 01-12 10:53
嘉和生物盘中异动 早盘股价大跌5.02%
嘉和生物盘中异动 下午盘快速下跌5.11%
市场透视 · 01-09
嘉和生物盘中异动 下午盘快速下跌5.11%
嘉和生物盘中异动 股价大跌5.47%报2.940港元
市场透视 · 01-08
嘉和生物盘中异动 股价大跌5.47%报2.940港元
嘉和生物01月06日主力净流入36.2万元 散户资金抛售
市场透视 · 01-06
嘉和生物01月06日主力净流入36.2万元 散户资金抛售
嘉和生物盘中异动 快速下跌5.00%报2.850港元
市场透视 · 01-02
嘉和生物盘中异动 快速下跌5.00%报2.850港元
异动解读 | 嘉和生物-B盘中大跌6.27%,港股通持股占比大幅减少
异动解读 · 2025-12-31
异动解读 | 嘉和生物-B盘中大跌6.27%,港股通持股占比大幅减少
嘉和生物盘中异动 大幅下挫6.90%
市场透视 · 2025-12-31
嘉和生物盘中异动 大幅下挫6.90%
亿腾医药,成功借壳嘉和生物,视作重新上市、今早正式生效,并更名为亿腾嘉和
瑞恩资本Ryanbe... · 2025-12-30
亿腾医药,成功借壳嘉和生物,视作重新上市、今早正式生效,并更名为亿腾嘉和
嘉和生物-B(06998)根据特定授权发行代价股份14.83亿股
中金财经 · 2025-12-30
嘉和生物-B(06998)根据特定授权发行代价股份14.83亿股
嘉和生物-B:根据特定授权发行约14.83亿股代价股份
格隆汇 · 2025-12-30
嘉和生物-B:根据特定授权发行约14.83亿股代价股份
亿腾嘉和医药(06998)增发约14.83亿股新股,已发行股本增至20.11亿股
公告速递 · 2025-12-30
亿腾嘉和医药(06998)增发约14.83亿股新股,已发行股本增至20.11亿股
异动解读 | 嘉和生物-B(06998)盘中大涨5.23%,因完成收购亿腾医药并更名
异动解读 · 2025-12-30
异动解读 | 嘉和生物-B(06998)盘中大涨5.23%,因完成收购亿腾医药并更名
嘉和生物-B(06998)完成建议合并 更名为“亿腾嘉和医药集团有限公司”
智通财经 · 2025-12-30
嘉和生物-B(06998)完成建议合并 更名为“亿腾嘉和医药集团有限公司”
嘉和生物-B:12月31日起公司英文及中文股份简称不再印有“B”标记
智通财经网 · 2025-12-22
嘉和生物-B:12月31日起公司英文及中文股份简称不再印有“B”标记
嘉和生物药业(6998)特别股东大会通过合并及更名 多项决议正式获批
公告速递 · 2025-12-22
嘉和生物药业(6998)特别股东大会通过合并及更名 多项决议正式获批
嘉和生物-B(06998)拟将法定股本增至6万美元
智通财经 · 2025-12-22
嘉和生物-B(06998)拟将法定股本增至6万美元
嘉和生物-B12月22日主力净流出51.1万元 散户资金买入
市场透视 · 2025-12-22
嘉和生物-B12月22日主力净流出51.1万元 散户资金买入
嘉和生物-B12月18日主力净流出23.7万元 散户资金买入
市场透视 · 2025-12-18
嘉和生物-B12月18日主力净流出23.7万元 散户资金买入
嘉和生物-B12月12日主力净流出21.6万元 散户资金买入
市场透视 · 2025-12-12
嘉和生物-B12月12日主力净流出21.6万元 散户资金买入
嘉和生物-B(06998):来罗西利(GB491)纳入国家医保药品目录
智通财经 · 2025-12-08
嘉和生物-B(06998):来罗西利(GB491)纳入国家医保药品目录
加载更多
公司概况
公司名称:
嘉和生物
所属市场:
SEHK
上市日期:
--
主营业务:
亿腾嘉和医药集团有限公司(原名:嘉和生物药业(开曼)控股有限公司)是一家主要从事开发及商业化肿瘤学及自身免疫性疾病药物的公司。该公司主营业务是从事人用生物制药产品的发现、研发及商业化。该公司产品管线包括来罗西利(GB491)、GB261、GB263T、英夫利西单抗(GB242)、Coprelotamab(GB221)、GB223、利妥昔单抗(GB241)、稳可信、希刻劳等产品,涵盖乳腺癌、肺癌、胃肠道肿瘤以及血液肿瘤等疾病领域。该公司主要在国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"06998","market":"HK","secType":"STK","nameCN":"嘉和生物","latestPrice":2.4,"timestamp":1768205308583,"preClose":2.59,"halted":0,"volume":3129000,"delay":0,"floatShares":2011000000,"shares":2011000000,"eps":-0.09986,"marketStatus":"未开盘","change":-0.19,"latestTime":"01-12 16:08:28","open":2.7,"high":2.7,"low":2.39,"amount":7692510,"amplitude":0.119691,"askPrice":2.43,"askSize":2000,"bidPrice":2.4,"bidSize":12000,"shortable":0,"etf":0,"ttmEps":0.016,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768267800000},"marketStatusCode":0,"adr":0,"listingDate":1602000000000,"exchange":"SEHK","adjPreClose":2.59,"openAndCloseTimeList":[[1768181400000,1768190400000],[1768194000000,1768204800000]],"volumeRatio":2.1016926381406025,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06998","defaultTab":"news","newsList":[{"id":"2602089598","title":"嘉和生物盘中异动 早盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602089598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602089598?lang=zh_cn&edition=full","pubTime":"2026-01-12 10:53","pubTimestamp":1768186428,"startTime":"0","endTime":"0","summary":"2026年01月12日早盘10时53分,嘉和生物股票出现异动,股价大幅下挫5.02%。截至发稿,该股报2.460港元/股,成交量80.05万股,换手率0.04%,振幅9.27%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。嘉和生物股票所在的生物技术行业中,整体涨幅为1.02%。其相关个股中,百奥赛图-B、瑞博生物-B、北海康成-B涨幅较大,振幅较大的相关个股有北海康成-B、百奥赛图-B、华生物-B,振幅分别为16.59%、15.54%、12.84%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112105348a4b8b759&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112105348a4b8b759&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","BK1161","06998"],"gpt_icon":0},{"id":"2602239773","title":"嘉和生物盘中异动 下午盘快速下跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602239773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602239773?lang=zh_cn&edition=full","pubTime":"2026-01-09 13:09","pubTimestamp":1767935395,"startTime":"0","endTime":"0","summary":"2026年01月09日下午盘13时09分,嘉和生物股票出现异动,股价大幅下跌5.11%。截至发稿,该股报2.600港元/股,成交量74.4万股,换手率0.04%,振幅5.84%。资金方面,该股资金流入28.9925万港元,流出164.231万港元。嘉和生物股票所在的生物技术行业中,整体跌幅为0.46%。其相关个股中,瑞博生物-B、迈博药业-B、思路迪医药股份涨幅较大,振幅较大的相关个股有拨康视云-B、瑞博生物-B、帝王国际投资,振幅分别为20.20%、18.46%、17.17%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109130955953c4478&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109130955953c4478&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","06998","BK1574","BK1161"],"gpt_icon":0},{"id":"2601271336","title":"嘉和生物盘中异动 股价大跌5.47%报2.940港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601271336","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601271336?lang=zh_cn&edition=full","pubTime":"2026-01-08 09:31","pubTimestamp":1767835902,"startTime":"0","endTime":"0","summary":"2026年01月08日早盘09时31分,嘉和生物股票出现异动,股价大幅下挫5.47%。截至发稿,该股报2.940港元/股,成交量8.55万股,换手率0.00%,振幅2.25%。资金方面,该股资金流入1.05万港元,流出24.08万港元。嘉和生物股票所在的生物技术行业中,整体涨幅为0.99%。其相关个股中,加科思-B、复宏汉霖、昭衍新药涨幅较大,振幅较大的相关个股有拨康视云-B、加科思-B、昭衍新药,振幅分别为5.15%、4.65%、3.62%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108093143a700bb27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108093143a700bb27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06998","BK1583","BK1574"],"gpt_icon":0},{"id":"2601589843","title":"嘉和生物01月06日主力净流入36.2万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2601589843","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601589843?lang=zh_cn&edition=full","pubTime":"2026-01-06 16:16","pubTimestamp":1767687367,"startTime":"0","endTime":"0","summary":"01月06日, 嘉和生物股价涨4.47%,报收3.04元,成交金额172.0万元,换手率0.03%,振幅5.50%,量比0.77。嘉和生物今日主力资金净流入36.2万元,上一交易日主力净流出0万元。该股近5个交易日下跌1.63%,主力资金累计净流入8.0万元;近20日主力资金累计净流出128.3万元,其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106162357a6f977e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106162357a6f977e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","06998","BK1574"],"gpt_icon":0},{"id":"2600065533","title":"嘉和生物盘中异动 快速下跌5.00%报2.850港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2600065533","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600065533?lang=zh_cn&edition=full","pubTime":"2026-01-02 13:08","pubTimestamp":1767330503,"startTime":"0","endTime":"0","summary":"2026年01月02日下午盘13时08分,嘉和生物股票出现波动,股价大幅下跌5.00%。截至发稿,该股报2.850港元/股,成交量68.9万股,换手率0.03%,振幅5.00%。资金方面,该股资金流入97.946万港元,流出99.585万港元。嘉和生物股票所在的生物技术行业中,整体涨幅为0.80%。其相关个股中,晶泰控股、翰思艾泰-B、旺山旺水-B涨幅较大,振幅较大的相关个股有轩竹生物-B、华昊中天医药-B、翰思艾泰-B,振幅分别为13.19%、13.09%、11.95%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102130823a6eab5c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102130823a6eab5c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","06998","BK1583"],"gpt_icon":0},{"id":"1173649246","title":"异动解读 | 嘉和生物-B盘中大跌6.27%,港股通持股占比大幅减少","url":"https://stock-news.laohu8.com/highlight/detail?id=1173649246","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173649246?lang=zh_cn&edition=full","pubTime":"2025-12-31 10:20","pubTimestamp":1767147621,"startTime":"0","endTime":"0","summary":"嘉和生物-B(06998)今日盘中股价大跌6.27%,引发市场关注。消息面上,根据最新港股通持股数据,嘉和生物-B的港股通持股占比近期出现显著下降。最新数据显示,该股港股通持股占比减少1.74%,最新持股比例仅为0.61%。在过去5个交易日内,其港股通持股占比同样减少了1.74%,显示机构投资者正在持续减持该股。分析人士指出,港股通资金的大幅流出可能是导致嘉和生物-B股价承压的主要原因。机构投资者的集中减持往往会对股价产生较大冲击,特别是在流动性相对较低的情况下。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["06998"],"gpt_icon":0},{"id":"2595776278","title":"嘉和生物盘中异动 大幅下挫6.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595776278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595776278?lang=zh_cn&edition=full","pubTime":"2025-12-31 10:11","pubTimestamp":1767147110,"startTime":"0","endTime":"0","summary":"2025年12月31日早盘10时11分,嘉和生物股票出现波动,股价快速下跌6.90%。截至发稿,该股报2.970港元/股,成交量28.8万股,换手率0.01%,振幅4.70%。嘉和生物股票所在的生物技术行业中,整体跌幅为0.43%。其相关个股中,拨康视云-B、翰思艾泰-B、派格生物医药-B涨幅较大,振幅较大的相关个股有拨康视云-B、翰思艾泰-B、华生物-B,振幅分别为10.93%、10.08%、9.05%。嘉和生物公司简介:嘉和生物药业(开曼)控股有限公司是一家主要从事生物制药业务的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231101150a6e37381&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231101150a6e37381&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06998","BK1574","BK1583","BK1161"],"gpt_icon":0},{"id":"2595754742","title":"亿腾医药,成功借壳嘉和生物,视作重新上市、今早正式生效,并更名为亿腾嘉和","url":"https://stock-news.laohu8.com/highlight/detail?id=2595754742","media":"瑞恩资本Ryanbe...","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595754742?lang=zh_cn&edition=full","pubTime":"2025-12-30 21:09","pubTimestamp":1767100179,"startTime":"0","endTime":"0","summary":"肿瘤及自体免疫药物的开发商嘉和生物药业于周二发布公告,与生物制药公司亿腾医药集团自2024年9月推进合并,后者通过反方向形式收购或借壳,视作重新上市,已于今早正式生效,并正式易名为亿腾嘉和,成为在香港首家生物医药或科技公司完成借壳合并的交易。是次嘉和生物药业合并的生物制药公司亿腾医药集团,面向抗感染、心血管及呼吸系统疾病等,从事原研药收购。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230220549a6e1ab29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230220549a6e1ab29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","06998","09939","BK1583","BK1515"],"gpt_icon":0},{"id":"2595579848","title":"嘉和生物-B(06998)根据特定授权发行代价股份14.83亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=2595579848","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595579848?lang=zh_cn&edition=full","pubTime":"2025-12-30 17:07","pubTimestamp":1767085629,"startTime":"0","endTime":"0","summary":"智通财经APP讯,嘉和生物-B(06998)发布公告,于2025年12月30日公司根据特定授权发行代价股份14.83亿股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251230/31903672.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1574","BK1161","BK1583","06998"],"gpt_icon":0},{"id":"2595742229","title":"嘉和生物-B:根据特定授权发行约14.83亿股代价股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2595742229","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595742229?lang=zh_cn&edition=full","pubTime":"2025-12-30 16:36","pubTimestamp":1767083760,"startTime":"0","endTime":"0","summary":"郑重声明:用户在社区发表的所有信息将由本网站记录保存,仅代表作者个人观点,与本网站立场无关,不对您构成任何投资建议,据此操作风险自担。请勿相信代客理财、免费荐股和炒股培训等宣传内容,远离非法证券活动。请勿添加发言用户的手机号码、公众号、微博、微信及QQ等信息,谨防上当受骗!","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163800a489830a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163800a489830a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","06998","BK1583"],"gpt_icon":0},{"id":"1106238325","title":"亿腾嘉和医药(06998)增发约14.83亿股新股,已发行股本增至20.11亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=1106238325","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106238325?lang=zh_cn&edition=full","pubTime":"2025-12-30 16:35","pubTimestamp":1767083743,"startTime":"0","endTime":"0","summary":"亿腾嘉和医药集团有限公司(06998)于2025年12月30日公布翌日披露报表,显示公司已依据特定授权发行约1,482,921,982股新股,增幅约占本次发行前公司已发行股份总数的280.7%。发行完成后,公司总股本由528,291,792股增至2,011,213,774股。\n公司披露,此次新股发行作为拟议合并的对价股份,相关详情已于2025年12月5日及12月30日的通函及公告中释出。每股发行价为3.56港元,发行过程均已获得公司董事会正式授权,并确认遵守香港联合交易所有限公司证券上市规则及其他相关法律法规要求。\n公告由联席公司秘书翟婧签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"gpt_icon":0},{"id":"1112263603","title":"异动解读 | 嘉和生物-B(06998)盘中大涨5.23%,因完成收购亿腾医药并更名","url":"https://stock-news.laohu8.com/highlight/detail?id=1112263603","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112263603?lang=zh_cn&edition=full","pubTime":"2025-12-30 09:33","pubTimestamp":1767058385,"startTime":"0","endTime":"0","summary":"嘉和生物-B今日盘中大涨5.23%,引起了市场的广泛关注。消息面上,嘉和生物-B宣布完成以合并方式收购亿腾医药,并更名为“亿腾嘉和医药集团有限公司”。根据公告,合并完成后,嘉和生物-B的全资附属公司GenEdd并入亿腾医药,亿腾医药作为存续实体成为公司的全资附属公司。同时,公司英文名称由“Genor Biopharma Holdings Limited”更改为“Edding Genor Group Holdings Limited”,中文名称由“嘉和生物药业(开曼)控股有限公司”更改为“亿腾嘉和医药集团有限公司”。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["06998"],"gpt_icon":0},{"id":"2595756465","title":"嘉和生物-B(06998)完成建议合并 更名为“亿腾嘉和医药集团有限公司”","url":"https://stock-news.laohu8.com/highlight/detail?id=2595756465","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595756465?lang=zh_cn&edition=full","pubTime":"2025-12-30 07:22","pubTimestamp":1767050556,"startTime":"0","endTime":"0","summary":"智通财经APP讯,嘉和生物-B 发布公告,完成建议合并的所有先决条件已获达成,且建议合并的完成已于2025年12月30日上午九时正作实。董事会欣然宣布,有关建议更改公司名称的特别决议案于股东特别大会上获股东批准后,本公司的英文名称已由“Genor Biopharma Holdings Limited”更改为“Edding Genor Group Holdings Limited”,而本公司的双重外文的中文名称已由“嘉和生物药业(开曼)控股有限公司”更改为“亿腾嘉和医药集团有限公司”,均自 2025年12月30日上午九时正起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386876.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","06998","BK1583"],"gpt_icon":0},{"id":"2593668934","title":"嘉和生物-B:12月31日起公司英文及中文股份简称不再印有“B”标记","url":"https://stock-news.laohu8.com/highlight/detail?id=2593668934","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593668934?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:40","pubTimestamp":1766392848,"startTime":"0","endTime":"0","summary":"智通财经APP讯,嘉和生物-B(06998)发布公告,根据上市规则第18A.12条向联交所提出申请后,联交所已授出批准上市规则第18A.09至18A.11条(相关规则)不适用于本公司,惟须待合并完成进行后方可作实。由于相关规则不适用并待合并完成于2025年12月30日(即通函所披露预期合并完成日期)进行后,自2025年12月31日(即紧随合并完成日期后的营业日(定义见上市规则))起,本公司的英文及中文股份简称不再印有“B”标记。本公司的股份代号维持不变,为“6998”。此外,本公司正进行建议更改公司名称后更改其股份简称,并将适时就有关新股份简称的生效日期另行刊发公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222164622a6c0aa17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222164622a6c0aa17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06998","BK1583","BK1574","BK1161"],"gpt_icon":0},{"id":"1114621399","title":"嘉和生物药业(6998)特别股东大会通过合并及更名 多项决议正式获批","url":"https://stock-news.laohu8.com/highlight/detail?id=1114621399","media":"公告速递","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114621399?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:36","pubTimestamp":1766392593,"startTime":"0","endTime":"0","summary":"嘉和生物药业(开曼)控股有限公司与标的公司的合并提案及多项相关议案,于2025年12月22日举行的股东特别大会上获得通过。会议审议并表决通过了包括清洗豁免、特别交易、增加法定股本以及一次性购股权计划在内的多项决议,为后续合并及业务发展铺路。嘉和生物药业指出,各项议案经股东高票通过后,将进一步落实与标的公司的合作事宜,有助于优化股权架构并提升公司的长远发展潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"gpt_icon":0},{"id":"2593883554","title":"嘉和生物-B(06998)拟将法定股本增至6万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593883554","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593883554?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:34","pubTimestamp":1766392447,"startTime":"0","endTime":"0","summary":"智通财经APP讯,嘉和生物-B 公布,由于股东已于股东特别大会上以投票表决方式通过批准建议更改公司名称的第6 项决议案,故于本公告日期,建议更改公司名称的条件已获达成。由于股东已于股东特别大会上以投票表决方式通过批准建议增加法定股本的第3 项决议案,公司法定股本已透过增设20亿股每股面值0.00002美元的股份,由2万美元增加至6万美元,该等股份在所有方面与公司现有股份享有同等地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384386.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","06998","BK1583"],"gpt_icon":0},{"id":"2593466831","title":"嘉和生物-B12月22日主力净流出51.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2593466831","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593466831?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:15","pubTimestamp":1766391322,"startTime":"0","endTime":"0","summary":"12月22日, 嘉和生物-B股价跌2.65%,报收3.31元,成交金额228.5万元,换手率0.13%,振幅7.65%,量比1.71。嘉和生物-B今日主力资金净流出51.1万元,上一交易日主力净流出0万元。该股近5个交易日下跌5.16%,主力资金累计净流出74.8万元;近20日主力资金累计净流出243.0万元,其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222161637a4697f63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222161637a4697f63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","06998","BK1161","BK1574"],"gpt_icon":0},{"id":"2592180192","title":"嘉和生物-B12月18日主力净流出23.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2592180192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592180192?lang=zh_cn&edition=full","pubTime":"2025-12-18 16:15","pubTimestamp":1766045747,"startTime":"0","endTime":"0","summary":"12月18日, 嘉和生物-B股价跌3.42%,报收3.39元,成交金额128.6万元,换手率0.07%,振幅4.84%,量比0.79。嘉和生物-B今日主力资金净流出23.7万元,上一交易日主力净流出0万元。该股近5个交易日下跌6.61%,主力资金累计净流出158.0万元;近20日主力资金累计净流出213.5万元,其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218162041a6b1a212&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218162041a6b1a212&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","06998","BK1161"],"gpt_icon":0},{"id":"2590504761","title":"嘉和生物-B12月12日主力净流出21.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2590504761","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590504761?lang=zh_cn&edition=full","pubTime":"2025-12-12 16:15","pubTimestamp":1765527340,"startTime":"0","endTime":"0","summary":"12月12日, 嘉和生物-B股价跌0.83%,报收3.60元,成交金额106.8万元,换手率0.06%,振幅4.96%,量比0.45。嘉和生物-B今日主力资金净流出21.6万元,上一交易日主力净流出0万元。该股近5个交易日下跌2.93%,主力资金累计净流出43.5万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出83.2万元,其中净流出天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121216245495397f6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121216245495397f6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06998","BK1583","BK1161"],"gpt_icon":0},{"id":"2589337909","title":"嘉和生物-B(06998):来罗西利(GB491)纳入国家医保药品目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2589337909","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589337909?lang=zh_cn&edition=full","pubTime":"2025-12-08 19:39","pubTimestamp":1765193995,"startTime":"0","endTime":"0","summary":"智通财经APP讯,嘉和生物-B 发布公告,来罗西利已纳入由国家医疗保障局于2025年12月7日发布的《国家基本医疗保险、生育保险和工伤保险药品目录》。此乃来罗西利首次被纳入国家医保药品目录。本公司相信,来罗西利进入医保目录,不仅能够极大的提升患者的用药可及性,减轻其经济负担,亦有力加速来罗西利的商业化进程和市场渗透,进一步提振创新回报。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378975.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"嘉和生物-B(06998):来罗西利(GB491)纳入国家医保药品目录","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1161","BK1574","06998"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.1753},{"period":"1month","weight":-0.3333},{"period":"3month","weight":-0.3277},{"period":"6month","weight":-0.0283},{"period":"1year","weight":0.2698},{"period":"ytd","weight":-0.2}],"compareEarnings":[{"period":"1week","weight":0.0099},{"period":"1month","weight":0.0243},{"period":"3month","weight":0.0459},{"period":"6month","weight":0.0853},{"period":"1year","weight":0.3957},{"period":"ytd","weight":0.0382}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"亿腾嘉和医药集团有限公司(原名:嘉和生物药业(开曼)控股有限公司)是一家主要从事开发及商业化肿瘤学及自身免疫性疾病药物的公司。该公司主营业务是从事人用生物制药产品的发现、研发及商业化。该公司产品管线包括来罗西利(GB491)、GB261、GB263T、英夫利西单抗(GB242)、Coprelotamab(GB221)、GB223、利妥昔单抗(GB241)、稳可信、希刻劳等产品,涵盖乳腺癌、肺癌、胃肠道肿瘤以及血液肿瘤等疾病领域。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.07543},{"month":2,"riseRate":0.4,"avgChangeRate":-0.004657},{"month":3,"riseRate":0.6,"avgChangeRate":0.024884},{"month":4,"riseRate":0.4,"avgChangeRate":-0.110106},{"month":5,"riseRate":0.6,"avgChangeRate":0.031188},{"month":6,"riseRate":0.6,"avgChangeRate":0.043248},{"month":7,"riseRate":0.4,"avgChangeRate":-0.090168},{"month":8,"riseRate":0.4,"avgChangeRate":0.095631},{"month":9,"riseRate":0.4,"avgChangeRate":-0.083466},{"month":10,"riseRate":0.4,"avgChangeRate":-0.052461},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.008673},{"month":12,"riseRate":0.666667,"avgChangeRate":0.044784}],"exchange":"SEHK","name":"嘉和生物","nameEN":"GENOR"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"嘉和生物(06998)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供嘉和生物(06998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"嘉和生物,06998,嘉和生物股票,嘉和生物股票老虎,嘉和生物股票老虎国际,嘉和生物行情,嘉和生物股票行情,嘉和生物股价,嘉和生物股市,嘉和生物股票价格,嘉和生物股票交易,嘉和生物股票购买,嘉和生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"嘉和生物(06998)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供嘉和生物(06998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}